問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
鄭媚方
下載
2023-05-02 - 2027-03-19
Condition/Disease
Plasma Cell Myeloma Recurrent
Test Drug
Isatuximab
Participate Sites3Sites
Not yet recruiting2Sites
Recruiting1Sites
2024-06-01 - 2028-12-31
Participate Sites2Sites
Recruiting2Sites
2024-09-01 - 2028-06-30
Participate Sites4Sites
Recruiting4Sites
2025-01-01 - 2026-12-31
Participate Sites1Sites
2025-01-01 - 2027-12-31
2024-10-01 - 2030-12-31
2025-01-07 - 2027-12-31
2023-08-01 - 2026-07-31
2025-03-07 - 2032-02-28
Recruiting3Sites
2021-05-18 - 2026-08-21
Participate Sites7Sites
Recruiting7Sites
全部
